NovaBone receives FDA approval for MIS system: 5 things to know

Laura Dyrda -   Print  |

NovaBone received FDA approval for the NovaBone MacroFORM MIS Delivery System designed for minimally invasive orthopedic procedures.

Here are five things to know:


1. The system was developed for surgeons requiring controlled and precise delivery of bone grafting material to surgical sites that aren't readily accessible.


2. The system allows surgeons to deliver bone marrow aspirate to a graft housed in a closed, ready to use minimally invasive cannula.


3. NovaBone released six new collagen products in the last 12 months based on the company's regenerative medicine technology and core competencies in designing innovative and cost-effective medical devices.


4. NovaBone's MacroFORM technology offers bioactivity and is available in multiple formulations and delivery options.


5. NovaBone is a privately-held company based in Florida.


More articles on orthopedic devices:
ECM Medcial to distribute Vertebral Technologies' Interfuse System in China
MIS SI joint fusion: Are outcomes positive? 10 things to know on 3 new studies
Amedica releases lumbar interbody spinal fusion device

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers